BioTime (BTX)/Asterias (AST) Conclude Recruitment for SCiStar Phase 1/2a Dose-Escalation Trial of AST-OPC1 for SCI
Tweet Send to a Friend
BioTime, Inc. (NYSE: BTX) announced today that subsidiary Asterias Biotherapeutics, Inc., (NYSE: AST) a biotechnology company focused on the emerging ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE